185 related articles for article (PubMed ID: 30021386)
1. MiR-363-3p suppresses tumor growth and metastasis of colorectal cancer via targeting SphK2.
Dong J; Geng J; Tan W
Biomed Pharmacother; 2018 Sep; 105():922-931. PubMed ID: 30021386
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of miR-301a-3p promotes colorectal cancer cell proliferation and metastasis by targeting deleted in liver cancer-1 and runt-related transcription factor 3.
Zhang L; Zhang Y; Zhu H; Sun X; Wang X; Wu P; Xu X
J Cell Biochem; 2019 Apr; 120(4):6078-6089. PubMed ID: 30362160
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-519d-3p inhibits cell proliferation and migration by targeting TROAP in colorectal cancer.
Ye X; Lv H
Biomed Pharmacother; 2018 Sep; 105():879-886. PubMed ID: 30021381
[TBL] [Abstract][Full Text] [Related]
4. MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor.
Shen K; Liang Q; Xu K; Cui D; Jiang L; Yin P; Lu Y; Li Q; Liu J
Biochem Pharmacol; 2012 Aug; 84(3):320-30. PubMed ID: 22580051
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
Xu X; Chen R; Li Z; Huang N; Wu X; Li S; Li Y; Wu S
BMC Cancer; 2015 Dec; 15():1023. PubMed ID: 26714817
[TBL] [Abstract][Full Text] [Related]
6. CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis.
Li Z; Yao H; Wang S; Li G; Gu X
J Exp Clin Cancer Res; 2020 Aug; 39(1):160. PubMed ID: 32799891
[TBL] [Abstract][Full Text] [Related]
7. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
[TBL] [Abstract][Full Text] [Related]
8. miR-140-3p inhibits colorectal cancer progression and its liver metastasis by targeting BCL9 and BCL2.
Liu D; Chen C; Cui M; Zhang H
Cancer Med; 2021 May; 10(10):3358-3372. PubMed ID: 33838016
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine.
Liu M; Xu A; Yuan X; Zhang Q; Fang T; Wang W; Li C
J Transl Med; 2015 Jun; 13():195. PubMed ID: 26084278
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-488 inhibits progression of colorectal cancer via inhibition of the mitogen-activated protein kinase pathway by targeting claudin-2.
Wang YB; Shi Q; Li G; Zheng JH; Lin J; Qiu W
Am J Physiol Cell Physiol; 2019 Jan; 316(1):C33-C47. PubMed ID: 30207785
[TBL] [Abstract][Full Text] [Related]
12. MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4.
Hu F; Min J; Cao X; Liu L; Ge Z; Hu J; Li X
Biochem Biophys Res Commun; 2016 May; 474(1):35-42. PubMed ID: 27084453
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
[TBL] [Abstract][Full Text] [Related]
14. miR-142-3p Suppresses Cell Growth by Targeting CDK4 in Colorectal Cancer.
Zhu X; Ma SP; Yang D; Liu Y; Wang YP; Lin T; Li YX; Yang SH; Zhang WC; Wang XL
Cell Physiol Biochem; 2018; 51(4):1969-1981. PubMed ID: 30513513
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression.
Bai R; Weng C; Dong H; Li S; Chen G; Xu Z
Int J Cancer; 2015 Nov; 137(10):2310-22. PubMed ID: 25991585
[TBL] [Abstract][Full Text] [Related]
16. LINC00261 suppresses human colon cancer progression via sponging miR-324-3p and inactivating the Wnt/β-catenin pathway.
Yan D; Liu W; Liu Y; Luo M
J Cell Physiol; 2019 Dec; 234(12):22648-22656. PubMed ID: 31183860
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-518a-3p activates the NIK-dependent NF-κB pathway in colorectal cancer.
Qu LL; He L; Zhao X; Xu W
Int J Mol Med; 2015 May; 35(5):1266-72. PubMed ID: 25812680
[TBL] [Abstract][Full Text] [Related]
18. BATF3 promotes malignant phenotype of colorectal cancer through the S1PR1/p-STAT3/miR-155-3p/WDR82 axis.
Li P; Weng Z; Li P; Hu F; Zhang Y; Guo Z; Shen W; Zhao C; Dai S
Cancer Gene Ther; 2021 May; 28(5):400-412. PubMed ID: 33057139
[TBL] [Abstract][Full Text] [Related]
19. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
Gao S; Liu H; Hou S; Wu L; Yang Z; Shen J; Zhou L; Zheng SS; Jiang B
Clin Transl Oncol; 2018 Jun; 20(6):703-712. PubMed ID: 29071516
[TBL] [Abstract][Full Text] [Related]
20. MiR-377-3p suppresses colorectal cancer through negative regulation on Wnt/β-catenin signaling by targeting XIAP and ZEB2.
Huang L; Liu Z; Hu J; Luo Z; Zhang C; Wang L; Wang Z
Pharmacol Res; 2020 Jun; 156():104774. PubMed ID: 32220639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
